[VRDN] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
08-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- 20.50%
YoY- 30.83%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 54 0 168 828 880 695 2,514 -92.18%
PBT -90,742 -5,494 -6,435 -8,044 -10,118 -11,230 -8,896 367.03%
Tax 130 -48 33 27 50 133 204 -25.84%
NP -90,742 -5,494 -6,435 -8,044 -10,118 -11,230 -8,896 367.03%
Tax Rate - - - - - - - -
Total Cost 90,796 5,494 6,603 8,872 10,998 11,925 11,410 296.08%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -168,040.74 0.00 -3,830.36 -971.50 -1,149.77 -1,615.83 -353.86 5874.17%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -23.07 -1.48 -1.82 -2.65 -4.69 -5.42 -4.31 204.44%
EPS Diluted -23.07 -1.48 -1.82 -2.65 -4.69 -5.42 -4.31 204.44%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.